Common Equity: The sum of all common equity items.
Vertex Pharmaceuticals Incorporated (VRTX) had Common Equity of $17.58B for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
$2.52B |
|
$968.80M |
|
$368.00M |
|
$2.15B |
|
$1.53B |
|
$988.50M |
|
$159.10M |
|
$1.15B |
|
$1.15B |
|
$968.80M |
|
$968.80M |
|
$968.80M |
|
$968.80M |
|
$988.50M |
|
$1.05B |
|
257.70M |
|
260.50M |
|
$3.77 |
|
$3.71 |
|
| Balance Sheet Financials | |
$14.14B |
|
$1.16B |
|
$8.59B |
|
$22.73B |
|
$3.55B |
|
$376.10M |
|
$1.60B |
|
$5.15B |
|
|
Common Equity |
$17.58B |
$15.65B |
|
$17.58B |
|
257.69M |
|
| Cash Flow Statement Financials | |
$3.54B |
|
$-3.14B |
|
$-562.20M |
|
$10.51B |
|
$10.37B |
|
$-139.70M |
|
$581.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.99 |
|
-- |
|
-- |
|
0.02 |
|
0.02 |
|
85.38% |
|
39.26% |
|
39.26% |
|
-- |
|
45.58% |
|
38.48% |
|
$3.34B |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.50 |
|
1.61 |
|
55.89 |
|
5.51% |
|
6.19% |
|
4.26% |
|
5.40% |
|
$68.22 |
|
$12.81 |
|
$13.58 |
|